The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://aprilwqnn577412.mywikiparty.com/2003164/retatrutide_vs_tirzepatide_a_comparative_analysis